Literature DB >> 11232769

Inducible nitric oxide synthase inhibition delays death of rabies virus-infected mice.

Sukathida Ubol, Chareeporn Sukwattanapan, Yaowapa Maneerat1.   

Abstract

A pathophysiological mechanism of cerebral damage and impairment of neuronal function during rabies virus infection was examined. Synthesis of nitric oxide (NO) and expression of the inducible nitric oxide synthase (iNOS) gene are strongly upregulated during rabies virus infection. Treatment of rabies virus-infected mice with a selective inhibitor of iNOS, aminoguanidine (AG), significantly delayed their death. Prolonged survival was not due to suppression of an inflammatory response in the central nervous system. One effect of iNOS inhibition was at the level of viral replication. Treatment with AG delayed rabies virus replication by 2 days. Moreover, iNOS inhibition also suppressed an early phase of expression of an apoptotic gene, Caspase-1, which resulted in slow progression of infected cells into apoptotic death. iNOS inhibition had no effect on expression of the anti-apoptotic gene, bcl-2. In conclusion, iNOS inhibition delayed the death of rabies virus-infected mice by affecting viral replication and apoptotic death of infected cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11232769     DOI: 10.1099/0022-1317-50-3-238

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  15 in total

1.  Region at amino acids 164 to 303 of the rabies virus glycoprotein plays an important role in pathogenicity for adult mice.

Authors:  Mutsuyo Takayama-Ito; Naoto Ito; Kentaro Yamada; Nobuyuki Minamoto; Makoto Sugiyama
Journal:  J Neurovirol       Date:  2004-04       Impact factor: 2.643

Review 2.  Perspectives in Diagnosis and Treatment of Rabies Viral Encephalitis: Insights from Pathogenesis.

Authors:  Anita Mahadevan; M S Suja; Reeta S Mani; Susarala K Shankar
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

3.  Role of nitric oxide in the regulation of immune responses during rabies virus infection in mice.

Authors:  B P Madhu; K P Singh; M Saminathan; R Singh; N Shivasharanappa; A K Sharma; Yashpal S Malik; K Dhama; V Manjunatha
Journal:  Virusdisease       Date:  2016-09-01

Review 4.  Neuronal dysfunction and death in rabies virus infection.

Authors:  Zhen F Fu; Alan C Jackson
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

5.  Correlation of inducible nitric oxide synthase (iNOS) inhibition with TNF-α, caspase-1, FasL and TLR-3 in pathogenesis of rabies in mouse model.

Authors:  B P Madhu; K P Singh; M Saminathan; R Singh; A K Tiwari; V Manjunatha; C Harish; G B Manjunathareddy
Journal:  Virus Genes       Date:  2015-12-21       Impact factor: 2.332

6.  Inhibition of MALT1 Decreases Neuroinflammation and Pathogenicity of Virulent Rabies Virus in Mice.

Authors:  S Van Gucht; R Beyaert; E Kip; J Staal; H G Tima; L Verstrepen; M Romano; K Lemeire; V Suin; A Hamouda; M Baens; C Libert; M Kalai
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

Review 7.  The cell biology of rabies virus: using stealth to reach the brain.

Authors:  Matthias J Schnell; James P McGettigan; Christoph Wirblich; Amy Papaneri
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

Review 8.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Astrovirus-induced synthesis of nitric oxide contributes to virus control during infection.

Authors:  Matthew D Koci; Laura A Kelley; Diane Larsen; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Rabies virus stimulates nitric oxide production and CXC chemokine ligand 10 expression in macrophages through activation of extracellular signal-regulated kinases 1 and 2.

Authors:  Kazuo Nakamichi; Satoshi Inoue; Tomohiko Takasaki; Kinjiro Morimoto; Ichiro Kurane
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.